Iovance Biotherapeutics
Luke Renaud is an accomplished MSAT Scientist I at Iovance Biotherapeutics, Inc., with a robust background in aseptic manufacturing processes for GMP cell therapy. With experience in roles such as Lead Aseptic Manufacturing Technician and Senior Aseptic Manufacturing Specialist, Renaud has demonstrated expertise in executing and troubleshooting complex manufacturing processes, supporting technical transfers, and collaborating with cross-functional teams on various departmental projects. Prior to Iovance, Renaud held positions at Rowan University School of Osteopathic Medicine and New Jersey Institute of Technology, where responsibilities included preparing solutions for experiments and conducting environmental research. Renaud holds a Bachelor's Degree in Chemical Engineering from New Jersey Institute of Technology and a Bachelor's degree from Calvary Chapel Bible College.
This person is not in any teams
This person is not in any offices
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.